Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dal-Ré, Rafael
638  Ergebnisse:
Personensuche X
?
1

Is "interventional trial" a correct term to use in clinical..:

Dal-Ré, Rafael
European Journal of Clinical Pharmacology.  80 (2024)  7 - p. 1107-1109 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Challenges in conducting efficacy trials for new COVID-19 v..:

Dal-Ré, Rafael ; Bottieau, Emmanuel ; Launay, Odile..
Clinical Trials.  , 2024
Link: https://doi.org/10.1177/..
 
?
3

Revisión por pares: consideraciones a las propuestas de Can..:

Dal-Ré, Rafael
Anales de Pediatría.  100 (2024)  4 - p. 311-312 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Adequate information about clinical trial results must be g..:

Dal-Ré, Rafael ; Caplan, Arthur L. ; Holm, Søren..
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
5

Peer-review: Considerations to Candal-Pedreira et al.'s pro..:

Dal-Ré, Rafael
Anales de Pediatría (English Edition).  100 (2024)  4 - p. 311-312 , 2024
Link: https://doi.org/10.1016/..
 
?
6

The definition of research misconduct should be stated in t..:

Dal-Ré, Rafael ; Marušić, Ana
Accountability in Research.  , 2024
Link: https://doi.org/10.1080/..
 
?
7

Voluntary transparency of sponsors of medicines clinical tr..:

Dal-Ré, Rafael
Journal of Clinical Epidemiology.  169 (2024)  - p. 111282 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Is full transparency in clinical trials an achievable goal?:

Dal-Ré, Rafael
European Journal of Internal Medicine.  123 (2024)  - p. 1-3 , 2024
Link: https://doi.org/10.1016/..
 
?
9

'Pragmatic' or 'streamlined': Which term best fits the REMA..:

Dal-Ré, Rafael
European Journal of Internal Medicine.  113 (2023)  - p. 119-121 , 2023
Link: https://doi.org/10.1016/..
 
?
10

COVID-19 research waste: An analysis on terminated clinical..:

Dal-Ré, Rafael
European Journal of Internal Medicine.  117 (2023)  - p. 126-128 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Waivers of informed consent in research with competent part..:

Dal-Ré, Rafael
European Journal of Clinical Pharmacology.  79 (2023)  4 - p. 575-578 , 2023
Link: https://doi.org/10.1007/..
 
?
12

'Time out'—more transparency is required in 'Just-in-time' ..:

Dal-Ré, Rafael ; Caplan, Arthur L ; Voo, Teck Chuan
European Journal of Internal Medicine.  108 (2023)  - p. 100-101 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Informed consent process in the I-SPY COVID trial is questi..:

Dal-Ré, Rafael ; Caplan, Arthur L ; Voo, Teck Chuan
European Journal of Internal Medicine.  107 (2023)  - p. 98-99 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Using the phases of clinical development of medicines to de..:

Dal-Ré, Rafael ; Banzi, Rita ; Cristea, Ioana A....
Journal of Clinical Epidemiology.  161 (2023)  - p. 157-163 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Leading pharmaceutical companies lacked transparency on cli..:

Dal-Ré, Rafael ; Voo, Teck Chuan ; Holm, Søren
Journal of Clinical Epidemiology.  162 (2023)  - p. 187-189 , 2023
Link: https://doi.org/10.1016/..
 
1-15